Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by BigPoppaStockon Aug 12, 2019 11:23pm
116 Views
Post# 30020571

RE:RE:RE:Tomorrow....

RE:RE:RE:Tomorrow....I especially love this quote from Patrick McCutcheon:

"the successful ramp up of our Canadian and Australian facilities will drive growth and value for the remainder of this year and well beyond.”

No reason to jump ship hear.  This is a growth story you want to be a part of.  I don't see a need for near-term dilution with the cash they now have on hand.  Only way to buy now is in the open market.

If someone wanted to buy MediPharm, they would have to pay a significant premium at this point.  I don't think the plan is to sell anytime soon.  Medipharm have a plan and if executed properly, the outcome would reap the biggest reward to all. 

Park your cash and let the industry unfold.  Cannabis 2.0 around the corner, ramp up of production, higher margin product development, Australia coming onboard, EU GMP certification, global expansion.

Bullboard Posts